{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:01:48Z","timestamp":1791910908429,"version":"4.3.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.parkreldis.2020.11.026","type":"journal-article","created":{"date-parts":[[2020,11,30]],"date-time":"2020-11-30T02:08:49Z","timestamp":1606702129000},"page":"117-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["FXTAS presents with upregulation of the cytokines IL12 and TNF\u03b1"],"prefix":"10.1016","volume":"82","author":[{"given":"Brett D.","family":"Dufour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarwat","family":"Amina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Martinez-Cerdeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.parkreldis.2020.11.026_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrneurol.2016.82","article-title":"Fragile X-associated tremor\/ataxia syndrome - features, mechanisms and management","volume":"12","author":"Hagerman","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.parkreldis.2020.11.026_bib2","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1172\/JCI90609","article-title":"CNS inflammation and neurodegeneration","volume":"127","author":"Chitnis","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.parkreldis.2020.11.026_bib3","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.parkreldis.2020.11.026_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"issue":"Pt 1","key":"10.1016\/j.parkreldis.2020.11.026_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/brain\/awh683","article-title":"Neuropathology of fragile X-associated tremor\/ataxia syndrome (FXTAS)","volume":"129","author":"Greco","year":"2006","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.parkreldis.2020.11.026_bib6","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/mds.27553","article-title":"Microglial cell activation and senescence are characteristic of the pathology FXTAS","volume":"33","author":"Martinez Cerdeno","year":"2018","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2020.11.026_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pharmthera.2004.11.007","article-title":"Cytokines in multiple sclerosis: from bench to bedside","volume":"106","author":"Imitola","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.parkreldis.2020.11.026_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","article-title":"TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects","volume":"302","author":"Probert","year":"2015","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.parkreldis.2020.11.026_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/glia.20235","article-title":"Cytokine toxicity to oligodendrocyte precursors is mediated by iron","volume":"52","author":"Zhang","year":"2005","journal-title":"Glia"},{"issue":"4","key":"10.1016\/j.parkreldis.2020.11.026_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mds.26902","article-title":"Iron accumulation and dysregulation in the putamen in fragile X-associated tremor\/ataxia syndrome","volume":"32","author":"Ariza","year":"2017","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2020.11.026_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094475","article-title":"Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses","volume":"9","author":"Careaga","year":"2014","journal-title":"PloS One"},{"issue":"18","key":"10.1016\/j.parkreldis.2020.11.026_bib12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/WNR.0000000000000905","article-title":"Adult Fmr1 knockout mice present with deficiencies in hippocampal interleukin-6 and tumor necrosis factor-alpha expression","volume":"28","author":"Hodges","year":"2017","journal-title":"Neuroreport"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020308786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020308786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:21:25Z","timestamp":1761178885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020308786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":12,"alternative-id":["S1353802020308786"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.026","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FXTAS presents with upregulation of the cytokines IL12 and TNF\u03b1","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}